Day: November 2, 2020

PORTLAND, Ore., Nov. 02, 2020 (GLOBE NEWSWIRE) — On November 2, 2020, Schmitt Industries, Inc. (NASDAQ: SMIT) (the “Company” or “Schmitt”) received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based on the October 30, 2020 filing of the Company’s Form 10-Q for the period ended August 31, 2020, the Company is now in compliance with NASDAQ’s listing requirements.About Schmitt IndustriesSchmitt Industries, Inc., founded in 1987, designs, manufactures and sells high precision test and measurement products, solutions and services through its Acuity® and Xact® product lines. Acuity provides laser and white light sensor distance measurement and dimensional sizing products, and our Xact line provides ultrasonic-based remote tank monitoring products...

DALLAS, Nov. 02, 2020 (GLOBE NEWSWIRE) — Triumph Bancorp, Inc. (Nasdaq: TBK) (“the Company”) announced today that Douglas M. Kratz, who has been a member of the Company’s Board of Directors since 2013, has retired from the Board of the Directors of the Company effective October 29, 2020. Kratz, age 69, retired in the days following the Company’s final regularly scheduled board meeting for the year to attend to ongoing health matters.“Doug has been an invaluable source of guidance and expertise for our Board since our acquisition of National Bancshares in 2013,” said the Company’s Chairman of the Board, Carlos M. Sepulveda, Jr. Aaron P. Graft, the Company’s Vice Chairman, President and Chief Executive Officer, added, “We wish to thank Doug for his years of service. We will be forever grateful for his many contributions and wish him...

SALT LAKE CITY, Nov. 02, 2020 (GLOBE NEWSWIRE) — Health Catalyst, Inc. (“Health Catalyst”, Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Patrick Nelli, Chief Financial Officer, and Adam Brown, Senior Vice President, Investor Relations, will participate in the 29th Annual Credit Suisse Virtual Healthcare Conference on Thursday, November 12, 2020, which will include a fireside chat presentation at 2:45 p.m. ET. A live audio webcast and replay of this presentation will be available at https://ir.healthcatalyst.com/investor-relations.About Health CatalystHealth Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare...

CAMBRIDGE, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in a fireside chat at the 29th Annual Credit Suisse Virtual Healthcare Conference on Monday, November 9, 2020 at 3:30 p.m. E.T.The presentation will be webcast live under the investor relations section of Sarepta’s website at www.sarepta.com and will be archived there following the presentation for 90 days. Please connect to Sarepta’s website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.About Sarepta TherapeuticsAt Sarepta, we are leading a revolution in precision genetic medicine and every day is an opportunity to change the lives of people...

Third Quarter SummaryNet income of $5.1 million, or $0.21 per fully diluted shareOngoing focus on reducing costs of deposits resulted in a decrease in interest expense over last quarter of $500 thousand, or 22.1%Interest income increased $436 thousand, and in combination with the decrease in interest expense resulted in an increase to net interest income of $936 thousand, or 7.0% over the prior quarterNoninterest income increased $1.1 million, or 91.7%, over the prior quarter as a result of gain on sale of SBA loans, increased service charges and fee incomeNoninterest bearing deposits increased $65.4 million, or 11.0%, from June 30, 2020, and $264.5 million, or 66.6%, from December 31, 2019Borrowings decreased to $24.0 million from $74.0 million the prior quarter, replaced with core deposit fundingNo provision for loan and lease losses...

COLORADO SPRINGS, CO, Nov. 02, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Gold Resource Corporation (NYSE American: GORO) (the “Company”, “We”, “Our” or “GRC”) reported consolidated production results for the third quarter ended September 30, 2020 of 12,575 gold ounces and 333,761 silver ounces.  In addition to precious metals, the Company produced base metals resulting in consolidated net revenue of $42.3 million for the quarter.  Gold Resource Corporation is a gold and silver producer, developer and explorer with operations in Oaxaca, Mexico and Nevada, USA.  The Company has returned $115 million to its shareholders in consecutive monthly dividends since July 2010 and offers its shareholders the option to convert their cash dividends into physical gold and silver and take delivery.“Our successful third quarter demonstrates...

RALEIGH, N.C., Nov. 02, 2020 (GLOBE NEWSWIRE) — Integrated Financial Holdings, Inc (formerly West Town Bancorp, Inc.) (OTC PINK: IFHI) (the “Company” or “IFH”), the financial holding company for West Town Bank & Trust (“the Bank”), released its financial results for the three and nine months ended September 30, 2020. Highlights include the following:Third quarter net income of $1.7 million or $0.78 per diluted share, compared to net income of $2.2 million or $0.91 per diluted share for the third quarter of 2019.   Income for 2019 was positively impacted by a nonrecurring adjustment which decreased loan and legal related expenses pertaining to the guaranteed loan portfolio as the Company was able to recapture some of its previously expensed costs resulting in a negative expense for that prior year quarter.Provision for loan...

EAGLE, Idaho, Nov. 02, 2020 (GLOBE NEWSWIRE) — The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced that it has acquired Riverside Home Health Care of Grants Pass, Oregon and serving Douglas, Jackson, and Josephine counties. The acquisition was effective November 1, 2020.“We are very pleased to announce the acquisition of Riverside Home Health Care,” said Daniel Walker, Pennant’s Chief Executive Officer. “This attractive off-market transaction is the result of a strong relationship developed over many years. We continue to source many such off-market opportunities in existing and new markets as operators increasingly recognize the value of our innovative operating model and ability to transact quickly and smoothly,” he added.“Riverside...

LONGUEUIL, Quebec, Nov. 02, 2020 (GLOBE NEWSWIRE) — Highland Copper Company Inc. (TSXV: HI, OTCQB: HDRSF) (the “Company”) announced today that the credit agreement with Osisko Gold Royalties Ltd (“Osisko”) and Greenstone Resources II LP entered into on May 20, 2019 was further amended. The maturity date for the repayment of the US$5,000,000 loan plus accrued interest was extended to November 30, 2020, provided however that the lenders may demand repayment of the loan and accrued interest at any time prior to the maturity date.In connection with the previous amendment of the credit agreement, Osisko and the Company had agreed on the terms and conditions pursuant to which Osisko would exercise its silver royalty option (see news release of September 11, 2020). The proposed transaction with Osisko was subject to certain conditions...

– Credit Suisse – 29th Annual Healthcare Conference –November 9th-12th– Stifel 2020 Virtual Healthcare Conference –November 16th-18thSOUTH SAN FRANCISCO, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) — Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA) a clinical-stage biopharmaceutical company, today announced that management will participate in the following conferences in the month of November. Please see additional details below:About Satsuma Pharmaceuticals and STS101Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company developing a novel therapeutic product for the acute treatment of migraine, STS101. STS101 is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate (DHE), which can be quickly and easily self-administered with a proprietary pre-filled,...